RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
9 Meters Biopharma - Stock

9 Meters Biopharma ROA 2024

9 Meters Biopharma ROA

-1.32

Ticker

NMTR

ISIN

US6544051096

WKN

A2P362

In 2024, 9 Meters Biopharma's return on assets (ROA) was -1.32, a 80.12% increase from the -0.73 ROA in the previous year.

9 Meters Biopharma Aktienanalyse

What does 9 Meters Biopharma do?

9 Meters Biopharma Inc is a company that specializes in researching, developing, and marketing innovative therapeutic treatment options for various chronic diseases. Founded in 2010, the company has since become a major player in the biopharmaceutical drug development industry. The main goal of 9 Meters Biopharma is to provide new and effective treatment options to patients suffering from chronic diseases. The company focuses on the areas of gastroenterology, oncology, autoimmune diseases, and rare diseases. Its business model is based on identifying promising drug candidates and conducting clinical trials to prove the effectiveness and safety of the drugs. Once a drug is successfully developed, the company focuses on marketing and distributing the medication. One of the company's key products is the drug NMIL1701, which is developed for the treatment of patients with celiac disease. The medication targets the breakdown of gluten, which is present in many foods and can cause an inappropriate immune response and chronic inflammation in the intestines of people with celiac disease. Additionally, the company is currently developing medications for the treatment of ulcerative colitis, Crohn's disease, and pancreatitis. It is also researching the development of drugs for the treatment of various cancers and autoimmune diseases, including multiple sclerosis, lupus, and rheumatoid arthritis. Another important aspect of 9 Meters Biopharma's activities is collaborating with other companies and organizations to accelerate and improve drug development. The company works with various academic institutions and research organizations to jointly work on the development of new therapies. Overall, 9 Meters Biopharma Inc has established itself as a dynamic and innovative company in the biopharmaceutical landscape. With its strong focus on the development of novel therapies and collaboration with other organizations, the company is likely to continue playing a major role in improving healthcare and treating chronic diseases. 9 Meters Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding 9 Meters Biopharma's Return on Assets (ROA)

9 Meters Biopharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing 9 Meters Biopharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider 9 Meters Biopharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in 9 Meters Biopharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about 9 Meters Biopharma Stock

What is the Return on Assets (ROA) of 9 Meters Biopharma this year?

The Return on Assets (ROA) of 9 Meters Biopharma is -1.32 undefined this year.

What was the ROA of 9 Meters Biopharma compared to the previous year?

The ROA of 9 Meters Biopharma has increased by 80.12% compared to the previous year.

What consequences do high ROA have for investors of 9 Meters Biopharma?

A high ROA is advantageous for investors of 9 Meters Biopharma, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in 9 Meters Biopharma?

A low ROA can be unfavorable for investors of 9 Meters Biopharma as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of 9 Meters Biopharma affect the company?

An increase in ROA of 9 Meters Biopharma can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of 9 Meters Biopharma impact the company?

A reduction in the ROA of 9 Meters Biopharma can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of 9 Meters Biopharma?

Some factors that can influence the ROA of 9 Meters Biopharma include revenue, operating costs, asset structure, and industry average.

Why is the ROA of 9 Meters Biopharma important for investors?

The ROA of 9 Meters Biopharma is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can 9 Meters Biopharma take to improve ROA?

To improve ROA, 9 Meters Biopharma can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does 9 Meters Biopharma pay?

Over the past 12 months, 9 Meters Biopharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 9 Meters Biopharma is expected to pay a dividend of 0 USD.

What is the dividend yield of 9 Meters Biopharma?

The current dividend yield of 9 Meters Biopharma is .

When does 9 Meters Biopharma pay dividends?

9 Meters Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of 9 Meters Biopharma?

9 Meters Biopharma paid dividends every year for the past 0 years.

What is the dividend of 9 Meters Biopharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is 9 Meters Biopharma located?

9 Meters Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von 9 Meters Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 9 Meters Biopharma from 7/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did 9 Meters Biopharma pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of 9 Meters Biopharma in the year 2023?

In the year 2023, 9 Meters Biopharma distributed 0 USD as dividends.

In which currency does 9 Meters Biopharma pay out the dividend?

The dividends of 9 Meters Biopharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von 9 Meters Biopharma

Our stock analysis for 9 Meters Biopharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 9 Meters Biopharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.